Having trouble accessing articles? Reset your cache.

Kite raises $20 million in series A

Cancer immunotherapy company Kite Pharma Inc. (Los Angeles, Calif.) raised $20 million in a series A round.

Read the full 171 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE